Nuveen’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.07M Buy
190,766
+7,382
+4% +$389K ﹤0.01% 1614
2025
Q4
$9.62M Buy
183,384
+543
+0.3% +$32.5K ﹤0.01% 1578
2025
Q3
$11.8M Sell
182,841
-2,012
-1% -$116K ﹤0.01% 1461
2025
Q2
$8.99M Buy
+184,853
New +$7.15M ﹤0.01% 1578
2024
Q4
Sell
-22,183
Closed -$1.04M 3328
2024
Q3
$1.04M Sell
22,183
-497
-2% -$25.2K ﹤0.01% 2741
2024
Q2
$1.22M Sell
22,680
-6,823
-23% -$395K ﹤0.01% 2627
2024
Q1
$2.01M Buy
29,503
+2,541
+9% +$182K ﹤0.01% 2402
2023
Q4
$1.69M Sell
26,962
-11,847
-31% -$655K ﹤0.01% 2489
2023
Q3
$1.76M Buy
38,809
+920
+2% +$47.5K ﹤0.01% 2348
2023
Q2
$2.13M Buy
+37,889
New +$2.15M ﹤0.01% 2317
2021
Q4
Sell
-138,987
Closed -$15.6M 3340
2021
Q3
$15.6M Buy
138,987
+6,596
+5% +$828K ﹤0.01% 1448
2021
Q2
$21.4M Buy
132,391
+25,001
+23% +$3.04M 0.01% 1314
2021
Q1
$13.1M Buy
107,390
+90
+0.1% +$13.6K ﹤0.01% 1625
2020
Q4
$16.4M Buy
107,300
+42,370
+65% +$5.01M 0.01% 1373
2020
Q3
$5.43M Buy
64,930
+45,231
+230% +$4.01M ﹤0.01% 1868
2020
Q2
$1.45M Sell
19,699
-4,173
-17% -$244K ﹤0.01% 2464
2020
Q1
$1.01M Sell
23,872
-7,949
-25% -$410K ﹤0.01% 2510
2019
Q4
$1.94M Sell
31,821
-495
-2% -$27K ﹤0.01% 2428
2019
Q3
$1.32M Buy
+32,316
New +$1.54M ﹤0.01% 2572

Other funds holding CRSP